|
1
|
Minamino T, Miyauchi H, Yoshida T, Ishida
Y, Yoshida H and Komuro I: Endothelial cell senescence in human
atherosclerosis: Role of telomere in endothelial dysfunction.
Circulation. 105:1541–1544. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen J and Goligorsky MS: Premature
senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol
Heart Circ Physiol. 290:H1729–H1739. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chou E, Suzuma I, Way KJ, Opland D,
Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP
and King GL: Decreased cardiac expression of vascular endothelial
growth factor and its receptors in insulin-resistant and diabetic
states: A possible explanation for impaired collateral formation in
cardiac tissue. Circulation. 105:373–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waltenberger J, Lange J and Kranz A:
Vascular endothelial growth factor-A-induced chemotaxis of
monocytes is attenuated in patients with diabetes mellitus: A
potential predictor for the individual capacity to develop
collaterals. Circulation. 102:185–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoon YS, Uchida S, Masuo O, Cejna M, Park
JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, et al:
Progressive attenuation of myocardial vascular endothelial growth
factor expression is a seminal event in diabetic cardiomyopathy:
Restoration of microvascular homeostasis and recovery of cardiac
function in diabetic cardiomyopathy after replenishment of local
vascular endothelial growth factor. Circulation. 111:2073–2085.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abaci A, Oğuzhan A, Kahraman S, Eryol NK,
Unal S, Arinç H and Ergin A: Effect of diabetes mellitus on
formation of coronary collateral vessels. Circulation.
99:2239–2242. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rivard A, Silver M, Chen D, Kearney M,
Magner M, Annex B, Peters K and Isner JM: Rescue of
diabetes-related impairment of angiogenesis by intramuscular gene
therapy with adeno-VEGF. Am J Pathol. 154:355–363. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhai YF, Ni J, Jiang GW, Lu J, Xing L,
Lincoln C, Carter KC, Janat F, Kozak D, Xu S, et al: VEGI, a novel
cytokine of the tumor necrosis factor family, is an angiogenesis
inhibitor that suppresses the growth of colon carcinomas in vivo.
Faseb J. 13:181–189. 1999.PubMed/NCBI
|
|
9
|
Chew LJ, Pan H, Yu J, Tian S, Huang WQ,
Zhang JY, Pang S and Li LY: A novel secreted splice variant of
vascular endothelial cell growth inhibitor. FASEB J. 16:742–744.
2002.PubMed/NCBI
|
|
10
|
Migone TS, Zhang J, Luo X, Zhuang L, Chen
C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, et al: TL1A is a
TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell
costimulator. Immunity. 16:479–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meylan F, Davidson TS, Kahle E, Kinder M,
Acharya K, Jankovic D, Bundoc V, Hodges M, Shevach EM, Keane-Myers
A, et al: The TNF-family receptor DR3 is essential for diverse T
cell-mediated inflammatory diseases. Immunity. 29:79–89. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bamias G, Martin C III, Marini M, Hoang S,
Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, et
al: Expression, localization and functional activity of TL1A, a
novel Th1-polarizing cytokine in inflammatory bowel disease. J
Immunol. 171:4868–4874. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang YJ, Kim WJ, Bae HU, Kim DI, Park YB,
Park JE, Kwon BS and Lee WH: Involvement of TL1A and DR3 in
induction of pro-inflammatory cytokines and matrix
metalloproteinase-9 in atherogenesis. Cytokine. 29:229–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim WJ, Kang YJ, Suk K, Park JE, Kwon BS
and Lee WH: Comparative analysis of the expression patterns of
various TNFSF/TNFRSF in atherosclerotic plaques. Immunol Invest.
37:359–373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang L, Adkins B, Deyev V and Podack ER:
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the
development of allergic lung inflammation. J Exp Med.
205:1037–1048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hampel B, Fortschegger K, Ressler S, Chang
MW, Unterluggauer H, Breitwieser A, Sommergruber W, Fitzky B,
Lepperdinger G, Jansen-Dürr P, et al: Increased expression of
extracellular proteins as a hallmark of human endothelial cell in
vitro senescence. Exp Gerontol. 41:474–481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng WM, Gu X, Lu Y, Gu C, Zheng Y, Zhang
Z, Chen L, Yao Z and Li LY: Down-modulation of TNFSF15 in ovarian
cancer by VEGF and MCP-1 is a pre-requisite for tumor
neovascularization. Angiogenesis. 15:71–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parr C, Gan CH, Watkins G and Jiang WG:
Reduced vascular endothelial growth inhibitor (VEGI) expression is
associated with poor prognosis in breast cancer patients.
Angiogenesis. 9:73–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Conway KP, Price P, Harding KG and Jiang
WG: The role of vascular endothelial growth inhibitor in wound
healing. Int Wound J. 4:55–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Ho FM, Lin WW, Chen BC, Chao CM, Yang CR,
Lin LY, Lai CC, Liu SH and Liau CS: High glucose-induced apoptosis
in human vascular endothelial cells is mediated through NF-kappa B
and c-Jun NH2-terminal kinase pathway and prevented by
PI3K/Akt/eNOS pathway. Cell Signal. 18:391–399. 2006. View Article : Google Scholar
|
|
22
|
Folkman J, Watson K, Ingber D and Hanahan
D: Induction of angiogenesis during the transition from hyperplasia
to neoplasia. Nature. 339:58–61. 1989. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang F, Tang Z, Hou X, Lennartsson J, Li
Y, Koch AW, Scotney P, Lee C, Arjunan P, Dong L, et al: VEGF-B is
dispensable for blood vessel growth but critical for their survival
and VEGF-B targeting inhibits pathological angiogenesis. P Natl
Acad Sci USA. 106:6152–6157. 2009. View Article : Google Scholar
|
|
24
|
Abid MR, Schoots IG, Spokes KC, Wu SQ,
Mawhinney C and Aird WC: Vascular endothelial growth
factor-mediated induction of manganese superoxide dismutase occurs
through redox-dependent regulation of forkhead and
IkappaB/NF-kappaB. J Biol Chem. 279:44030–44038. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu JY, Tian S, Metheny-Barlow L, Chew LJ,
Hayes AJ, Pan H, Yu GL and Li LY: Modulation of endothelial cell
growth arrest and apoptosis by vascular endothelial growth
inhibitor. Circ Res. 89:1161–1167. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mück C, Herndler-Brandstetter D, Micutkova
L, Grubeck-Loebenstein B and Jansen-Dürr P: Two functionally
distinct isoforms of TL1A (TNFSF15) generated by differential
ectodomain shedding. J Gerontol A Biol Sci Med Sci. 65:1165–1180.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qi JW, Qin TT, Xu LX, Zhang K, Yang GL, Li
J, Xiao HY, Zhang ZS and Li LY: TNFSF15 inhibits vasculogenesis by
regulating relative levels of membrane-bound and soluble isoforms
of VEGF receptor 1. P Natl Acad Sci USA. 110:13863–13868. 2013.
View Article : Google Scholar
|
|
28
|
Ho FM, Liu SH, Liau CS, Huang PJ and
Lin-Shiau SY: High glucose-induced apoptosis in human endothelial
cells is mediated by sequential activations of c-Jun NH2-terminal
kinase and caspase-3. Circulation. 101:2618–2624. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yue TL, Ni J, Romanic AM, et al: TL1, a
novel tumor necrosis factor-like cytokine, induces apoptosis in
endothelial cells-Involvement of activation of stress protein
kinases (stress-activated protein kinase and p38 mitogen-activated
protein kinase) and caspase-3-like protease. J Biol Chem.
274:1479–1486. 1999. View Article : Google Scholar : PubMed/NCBI
|
